Tarlatamab approved to treat adult patients with small cell lung cancer

31 December 2024 - The MHRA has today approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung ...

Read more →

Sotatercept approved to treat adult patients with pulmonary arterial hypertension

27 December 2024 - The MHRA has approved the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension. ...

Read more →

What price is society willing to pay for new drugs?

12 December 2024 - The purpose of England's NHS is to improve the health and wellbeing of the nation through provision ...

Read more →

Over 1,000 people with advanced breast cancer set to benefit from new once a day tablet

19 December 2024 - We’ve issued final draft guidance recommending a new once a day tablet that is set to benefit ...

Read more →

NICE recommends new treatment to prevent and reduce hearing loss in people being treated for cancer

20 December 2024 - For the first time, NICE has recommended an innovative new treatment to help stop babies, children and ...

Read more →

Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy

20 December 2024 - The MHRA has today granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne ...

Read more →

Ublituximab for the treatment of patients with relapsing multiple sclerosis

18 December 2024 - NICE has published final evidence-based recommendations on the use of ublituximab (Briumvi) for the treatment of ...

Read more →

What is NICE’s severity modifier?

15 December 2024 - A guide to the severity modifier and how it is leading to more positive recommendations overall from ...

Read more →

Should NICE’s cost effectiveness thresholds change?

13 December 2024 - We explore the on-going debate around NICE’s cost effectiveness thresholds and what the future holds. ...

Read more →

UK MHRA grants innovation passport designation to ILiAD Biotechnologies BPZE1 next generation intranasal pertussis vaccine

4 December 2024 - ILiAD Biotechnologies today announced that the UK MHRA has granted Innovation Passport designation to BPZE1, the leading ...

Read more →

Toripalimab in combination with chemotherapy for the first-line treatment of patients with advanced oesophageal squamous cell cancer

11 December 2024 - NICE is unable to make a recommendation on the use in the NHS of toripalimab (Loqtorzi) in ...

Read more →

New price deal paves way for NICE approval of treatment for rare genetic condition

10 December 2024 - A new treatment for Duchenne muscular dystrophy is set to be available to around 1,700 people in ...

Read more →

Cladribine for the treatment of patients with relapsing multiple sclerosis

6 December 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Ruxolitinib phosphate for the treatment of patients with acute graft versus host disease that responds inadequately to corticosteroids

6 December 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Molnupiravir for the treatment of patients with COVID-19 infection

26 November 2024 - NICE has published further draft guidance on the use of molnupiravir (Lagevrio) in the NHS in ...

Read more →